X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5438) 5438
animals (5375) 5375
male (3713) 3713
interleukin-1beta - metabolism (3301) 3301
mice (2709) 2709
inflammation (2506) 2506
humans (2487) 2487
rats (2180) 2180
cytokines (1784) 1784
female (1759) 1759
tumor necrosis factor-alpha - metabolism (1665) 1665
disease models, animal (1405) 1405
immunology (1402) 1402
interleukin-1beta - genetics (1284) 1284
expression (1169) 1169
mice, inbred c57bl (1089) 1089
rats, sprague-dawley (1015) 1015
activation (1004) 1004
interleukin-1beta - blood (909) 909
neurosciences (896) 896
cell biology (884) 884
interleukin-6 - metabolism (852) 852
cells, cultured (834) 834
rodents (819) 819
rats, wistar (817) 817
pharmacology & pharmacy (776) 776
il-1β (775) 775
interleukin-1beta - immunology (709) 709
oxidative stress (700) 700
research article (693) 693
gene expression (691) 691
analysis (670) 670
apoptosis (651) 651
tumor necrosis factor-alpha - genetics (638) 638
nf-kappa b - metabolism (632) 632
research (610) 610
biochemistry & molecular biology (575) 575
proteins (573) 573
nf-kappa-b (571) 571
tumor necrosis factor-alpha - blood (562) 562
cells (553) 553
medicine (545) 545
middle aged (541) 541
interleukin-1beta - pharmacology (539) 539
adult (534) 534
enzyme-linked immunosorbent assay (532) 532
interleukins (525) 525
health aspects (513) 513
macrophages (511) 511
rna, messenger - metabolism (503) 503
mice, knockout (495) 495
signal transduction (493) 493
anti-inflammatory agents - pharmacology (487) 487
brain (476) 476
tnf-alpha (472) 472
multidisciplinary sciences (468) 468
interleukin-1beta - biosynthesis (466) 466
inflammation - metabolism (462) 462
time factors (460) 460
dose-response relationship, drug (454) 454
inhibition (453) 453
signal transduction - drug effects (442) 442
interleukin-6 - blood (434) 434
disease (422) 422
cytokines - metabolism (417) 417
neurology (417) 417
cell line (416) 416
necrosis-factor-alpha (412) 412
mice, inbred balb c (406) 406
science (403) 403
lipopolysaccharides (400) 400
inflammation - drug therapy (384) 384
lipopolysaccharides - pharmacology (383) 383
medicine, research & experimental (376) 376
gene-expression (375) 375
physiological aspects (373) 373
rheumatology (366) 366
pathology (362) 362
interleukin-6 - genetics (360) 360
tumor-necrosis-factor (359) 359
care and treatment (358) 358
interleukin (354) 354
in-vitro (352) 352
mechanisms (348) 348
lipopolysaccharide (346) 346
tumor necrosis factor-tnf (346) 346
il-1 beta (343) 343
physiology (341) 341
nitric-oxide (340) 340
tumor necrosis factor-α (338) 338
interleukin 1 (334) 334
aged (330) 330
gene expression regulation - drug effects (329) 329
interleukin-1beta - antagonists & inhibitors (328) 328
pathogenesis (328) 328
oxidative stress - drug effects (325) 325
inflammation - pathology (316) 316
macrophages - metabolism (316) 316
cytokine (315) 315
immunohistochemistry (315) 315
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6570) 6570
Chinese (91) 91
Russian (36) 36
Japanese (35) 35
German (3) 3
French (2) 2
Korean (2) 2
Polish (2) 2
Ukrainian (2) 2
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Brain, Behavior, and Immunity, ISSN 0889-1591, 2015, Volume 51, pp. 204 - 211
Highlights • Endocannabinoids participate in the fever induced by TNF, IL-1β, IL-6, CRF and ET-1. • Endocannabinoids are not involved in the fever induced by... 
Psychiatry | Allergy and Immunology | Prostaglandins | Cytokines | β-Endorphin | Fever | Endocannabinoids | Anandamide | SYSTEM | ENDOGENOUS CANNABINOIDS | RECEPTOR-SELECTIVE ANTAGONIST | RATS | IMMUNOLOGY | NEUROSCIENCES | beta-Endorphin | ENDOTHELIAL-CELLS | INDEPENDENT FEVER | ANXIETY-LIKE | CANNABINOID 1 RECEPTORS | CB1 RECEPTORS | Narcotic Antagonists - administration & dosage | Rats, Wistar | Body Temperature - drug effects | Male | Fever - chemically induced | Cytokines - physiology | Fever - physiopathology | Receptor, Cannabinoid, CB1 - physiology | Endocannabinoids - physiology | Arachidonic Acids - administration & dosage | Interleukin-6 - physiology | Corticotropin-Releasing Hormone - administration & dosage | Interleukin-6 - administration & dosage | Arachidonic Acids - physiology | Interleukin-1beta - physiology | Piperidines - administration & dosage | beta-Endorphin - cerebrospinal fluid | Endothelin-1 - administration & dosage | Rats | Cytokines - administration & dosage | Polyunsaturated Alkamides - administration & dosage | Prostaglandins - physiology | Pyrazoles - administration & dosage | Animals | Endocannabinoids - administration & dosage | Interleukin-1beta - administration & dosage | Tumor Necrosis Factor-alpha - physiology | Tumor Necrosis Factor-alpha - administration & dosage | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Naloxone - administration & dosage | Prostaglandins - administration & dosage
Journal Article
Journal Article
Journal of Psychiatric Research, ISSN 0022-3956, 2013, Volume 47, Issue 10, pp. 1521 - 1529
Journal Article
Brain, Behavior, and Immunity, ISSN 0889-1591, 2016, Volume 57, pp. 360 - 370
Journal Article
Progress in neuro-psychopharmacology & biological psychiatry, ISSN 0278-5846, 2017, Volume 77, pp. 23 - 31
.... The aim of this study was to evaluate the effect of minocycline on memory, neurotrophins and neuroinflammation in an animal model of AD induced by the administration of Aβ (1-42) oligomer... 
Minocycline | Neuroinflammation | Neurotrophins | Alzheimer's disease | Spatial memory | NEUROFIBRILLARY TANGLES | MICROGLIAL ACTIVATION | HIPPOCAMPAL EXPRESSION | PSYCHIATRY | NEUROTROPHIC-FACTOR | NEURONAL CELL-DEATH | NECROSIS-FACTOR-ALPHA | MILD COGNITIVE IMPAIRMENT | NEUROSCIENCES | CLINICAL NEUROLOGY | NERVE GROWTH-FACTOR | ONSET ALZHEIMERS-DISEASE | PHARMACOLOGY & PHARMACY | TRANSGENIC MOUSE MODEL | Inflammation - chemically induced | Tumor Necrosis Factor-alpha - metabolism | Minocycline - pharmacology | Peptide Fragments - toxicity | Interleukin-10 - blood | Memory Disorders - metabolism | Male | Cerebral Cortex - metabolism | Inflammation - blood | Interleukin-1beta - blood | Brain - metabolism | Inflammation - metabolism | Neuroprotective Agents - pharmacology | Interleukin-1beta - metabolism | Interleukin-10 - metabolism | Brain-Derived Neurotrophic Factor - metabolism | Amyloid beta-Peptides - administration & dosage | Amyloid beta-Peptides - toxicity | Interleukin-4 - metabolism | Peptide Fragments - administration & dosage | Maze Learning - drug effects | Brain - drug effects | Memory Disorders - blood | Hippocampus - metabolism | Interleukin-4 - blood | Memory Disorders - prevention & control | Animals | Inflammation - prevention & control | Mice | Infusions, Intraventricular | Memory Disorders - chemically induced
Journal Article
The pharmacogenomics journal, ISSN 1473-1150, 2017, Volume 18, Issue 3, pp. 494 - 500
Biological agents including anti-tumor necrosis factor (anti-TNF; adalimumab, infliximab, etanercept) and anti-interleukin12/13 (111 2/2( L12/kinumab) are... 
ALLELE | INTERFERON-GAMMA | USTEKINUMAB | GENETICS & HEREDITY | TOLL-LIKE RECEPTORS | PHARMACOLOGY & PHARMACY | VARIANTS AFFECT | PROMOTER | GENE POLYMORPHISMS | CLINICAL-RESPONSE | ANTI-TNF-ALPHA | PREDICTION | Toll-Like Receptor 2 - genetics | Etanercept - administration & dosage | Humans | Middle Aged | Receptors, Interleukin-1 - genetics | Toll-Like Receptor 9 - genetics | Male | Interleukin-1beta - genetics | Infliximab - administration & dosage | Adalimumab - adverse effects | Lymphocyte Antigen 96 - genetics | Infliximab - adverse effects | Psoriasis - genetics | Psoriasis - pathology | Adult | Female | Ustekinumab - administration & dosage | Pharmacogenetics - methods | Etanercept - adverse effects | Psoriasis - drug therapy | Treatment Outcome | Ustekinumab - adverse effects | Membrane Glycoproteins - genetics | Psoriasis - epidemiology | Adalimumab - administration & dosage | Denmark | Polymorphism, Single Nucleotide | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Treatment outcome | Care and treatment | Pharmacogenetics | Pharmacology, Experimental | Psoriasis | Dosage and administration | Genetic aspects | Single nucleotide polymorphisms | Research | Biological response modifiers | Health aspects | TLR5 protein | Interleukin | Interleukin 12 | Pharmacology | Arthritis | Single-nucleotide polymorphism | Regression analysis | Tumor necrosis factor-α | Patients | TLR9 protein | Anticancer properties | Genetic variance | Etanercept | Infliximab | TLR2 protein | Interleukin 1 | Toll-like receptors | Monoclonal antibodies | Tumor necrosis factor-TNF | Interferon | Biological treatment | Polymorphism
Journal Article
European journal of nutrition, ISSN 1436-6215, 2017, Volume 57, Issue 5, pp. 1781 - 1791
... interleukin‑1β administration Yilong Dong1,4 · Min Xu4 · Allan V. Kalueff2,5,6 · Cai Song2,3 Received: 30 November 2016 / Accepted: 19 April 2017 / Published online: 18... 
Chemistry | Brain-derived neurotrophic factor | Nutrition | Proinflammatory cytokine | Inflammation | IL-1β | Eicosapentaenoic acid | NERVOUS-SYSTEM | ALZHEIMERS-DISEASE | RATS | NEURODEGENERATION | IL-1 beta | OMEGA-3-FATTY-ACID ETHYL-EICOSAPENTAENOATE | COGNITIVE DECLINE | NUTRITION & DIETETICS | BRAIN INFLAMMATION | DOCOSAHEXAENOIC ACID | SECRETION | ALPHA-LINOLENIC ACID | Fatty Acids, Omega-3 - metabolism | Humans | Rats, Long-Evans | Rodentia | Rats | Male | Eicosapentaenoic Acid - administration & dosage | Fatty Acids, Omega-6 - metabolism | Interleukin-1beta - adverse effects | Brain-Derived Neurotrophic Factor - drug effects | Canada | Hippocampus - metabolism | Animals | Interleukin-1beta - administration & dosage | Neuroprotective Agents - pharmacology | Brain-Derived Neurotrophic Factor - physiology | Eicosapentaenoic Acid - pharmacology | Neuroprotective Agents - administration & dosage | Animal models | Calcium | Polyunsaturated fatty acids | Glial cells | Neuronal-glial interactions | Neurodegeneration | Rodents | Down-regulation | Supplementation | Neurotrophins | Alzheimer's disease | CD11b antigen | Cytokines | Astrocytes | Glial fibrillary acidic protein | Dietary supplements | Tumor necrosis factor-α | Fatty acids | Amyloid precursor protein | Microglia | Phospholipase | Diet | TrkB receptors | Hippocampus
Journal Article